Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review

• Main Authors: Michelangela Barbieri (Author), Paolo Chiodini (Author), Piergiacomo Di Gennaro (Author), Gaye Hafez (Author), Sophie Liabeuf (Author), Jolanta Malyszko (Author), Laila-Yasmin Mani (Author), Francesco Mattace-Raso (Author), Marion Pepin (Author), Norberto Perico (Author), Mariadelina Simeoni (Author), Carmine Zoccali (Author), Giovanni Tortorella (Author), Annalisa Capuano (Author), Giuseppe Remuzzi (Author), Giovambattista Capasso (Author), Giuseppe Paolisso (Author)
• Format: Book
• Published: Elsevier, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Patients with chronic kidney disease (CKD) often experience mild cognitive impairment and other neurocognitive disorders. Studies have shown that erythropoietin (EPO) and its receptor have neuroprotective effects in cell and animal models of nervous system disorders. Recombinant human EPO (rHuEPO),...